Search research articles
Contact Us
Filters
Showing results (61-70 of 114) with videos related to
Page
of 12
Sort By:
Cancer Research
|
July 9, 2009
Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer
Thiruvengadam Arumugam, Vijaya Ramachandran, Keith F Fournier, et al.
Cancer
|
April 25, 2018
Potentially inappropriate medication use in older patients with breast and colorectal cancer
Meghan S Karuturi, Holly M Holmes, Xiudong Lei, et al.
BMC Cancer
|
September 8, 2016
The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study
Farshid Dayyani, Amado J Zurita, Graciela M Nogueras-González, et al.
Molecular Cancer Research : MCR
|
September 6, 2014
RSK promotes prostate cancer progression in bone through ING3, CKAP2, and PTK6-mediated cell survival
Guoyu Yu, Yu-Chen Lee, Chien-Jui Cheng, et al.
The Journal of Clinical Investigation
|
September 22, 2007
AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts
Jing Zhang, Serk In Park, Marlene C Artime, et al.
International Journal of Oncology
|
July 6, 2007
Lysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathway
Veronica C Estrella, Astrid M Eder, Shuying Liu, et al.
Molecular & Cellular Proteomics : MCP
|
December 21, 2014
Secretome analysis of an osteogenic prostate tumor identifies complex signaling networks mediating cross-talk of cancer and stromal cells within the tumor microenvironment
Yu-Chen Lee, Martina Srajer Gajdosik, Djuro Josic, et al.
Annals of Surgery
|
April 26, 2005
Insulinlike growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor
Todd W Bauer, Fan Fan, Wenbiao Liu, et al.
Gynecologic Oncology
|
December 31, 2002
Activated SRC protein tyrosine kinase is overexpressed in late-stage human ovarian cancers
Jon R Wiener, T Christopher Windham, Veronica C Estrella, et al.
Cancer Research
|
June 15, 2011
BMP4 promotes prostate tumor growth in bone through osteogenesis
Yu-Chen Lee, Chien-Jui Cheng, Mehmet A Bilen, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 114) with videos related to
Sort By:
Page
of 12
Cancer Research
|
July 9, 2009
Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer
Thiruvengadam Arumugam, Vijaya Ramachandran, Keith F Fournier, et al.
Cancer
|
April 25, 2018
Potentially inappropriate medication use in older patients with breast and colorectal cancer
Meghan S Karuturi, Holly M Holmes, Xiudong Lei, et al.
BMC Cancer
|
September 8, 2016
The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study
Farshid Dayyani, Amado J Zurita, Graciela M Nogueras-González, et al.
Molecular Cancer Research : MCR
|
September 6, 2014
RSK promotes prostate cancer progression in bone through ING3, CKAP2, and PTK6-mediated cell survival
Guoyu Yu, Yu-Chen Lee, Chien-Jui Cheng, et al.
The Journal of Clinical Investigation
|
September 22, 2007
AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts
Jing Zhang, Serk In Park, Marlene C Artime, et al.
International Journal of Oncology
|
July 6, 2007
Lysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathway
Veronica C Estrella, Astrid M Eder, Shuying Liu, et al.
Molecular & Cellular Proteomics : MCP
|
December 21, 2014
Secretome analysis of an osteogenic prostate tumor identifies complex signaling networks mediating cross-talk of cancer and stromal cells within the tumor microenvironment
Yu-Chen Lee, Martina Srajer Gajdosik, Djuro Josic, et al.
Annals of Surgery
|
April 26, 2005
Insulinlike growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor
Todd W Bauer, Fan Fan, Wenbiao Liu, et al.
Gynecologic Oncology
|
December 31, 2002
Activated SRC protein tyrosine kinase is overexpressed in late-stage human ovarian cancers
Jon R Wiener, T Christopher Windham, Veronica C Estrella, et al.
Cancer Research
|
June 15, 2011
BMP4 promotes prostate tumor growth in bone through osteogenesis
Yu-Chen Lee, Chien-Jui Cheng, Mehmet A Bilen, et al.
Page
of 12